Our mission is to discover and develop innovative therapies to transform the lives of people with rare central nervous system disorders.
Founded in 2009 by Karen Aiach, whose own child was affected by a neurodegenerative disease, Lysogene is rooted in a deep and compassionate understanding of the impact these diseases have on patients and families. Karen’s personal experience fuels her determination to deliver real solutions that will improve patient outcomes and enhance quality of life for both patients and caregivers.
Over the past 10 years, Lysogene has acquired deep experience in developing gene therapies—from early discovery through the clinical, registration and review phases. Our strong science and execution track record has been validated by our partnership with Sarepta Therapeutics and the support of top-tier investors, with nearly $100m raised since inception.
More information at www.lysogene.com
Location: France, Ile-de-France, Neuilly-sur-Seine
Member count: 11-50
Phone: +33 1 41 43 03 90
Total raised: $27.3429M
Founded date: 2009
Investors 1
| Date | Name | Website |
| - | Sofinnova ... | sofinnovap... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 26.11.2021 | - | $4.852336M | - | - |
| 23.05.2014 | Series A | $22.490564... | - | finsmes.co... |
Mentions in press and media 7
| Date | Title | Description | Category | Author | Source |
| 26.11.2021 | Lysogene S... | Lysogene S.A. announced that i... | - | - | marketscre... |
| 30.08.2021 | Lysogene :... | Second patient treated in the ... | - | - | marketscre... |
| 09.03.2021 | How Covid-... | Twenty years after researchers... | - | - | medcitynew... |
| 22.01.2015 | Regenxbio ... | Here’s how it works: In Hurler... | - | - | medcitynew... |
| 23.05.2014 | Lysogene R... | Lysogene, a Paris, Germany-bas... | France fu... | - | finsmes.co... |
| - | How Covid-... | Twenty years after researchers... | - | - | medcitynew... |
| - | Regenxbio ... | Washington, D.C.-based gene th... | - | - | medcitynew... |